International Journal of Clinical Pharmacy · 2018 · 149 citations · 4 references
PharmacyPharmacologyClinical PharmacologyPatient SafetyPharmacovigilanceAdverse Drug Event ReportingDrug SafetyDrug Safety MonitoringPharmacovigilance Data SourcesBenefit-risk RatioElectronic Pharmacovigilance ReportingHistory Of Scientific JournalsOverviewResearch JournalsRisk-benefit Ratio Assessment
Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient's safety and the quality of life. In this commentary we report the milestones of pharmacovigilance up to the present day, in order to understand all the steps that have characterized the historical evolution; from the first reports, which were essentially letters or warnings sent by clinicians to publishers of important and famous scientific journals, up to today's modern and ultra-structured electronic registries. The historical phases also help us to understand why pharmacovigilance helped us to achieve such important results for man's health and for pharmacology itself, and to identify the challenges that await Pharmacovigilance in future years.
4
THALIDOMIDE AND CONGENITAL ABNORMALITIES
W. G. McBride · The Lancet · 1961 · 1.1K citations
Medicine, Obstetrics, Pharmacology +16
150 years of pharmacovigilance
Philip A. Routledge · The Lancet · 1998 · 122 citations
The effect of thalidomide intake during 113 human pregnancies
Tadashi Kajii, M Kida, K. Takahashi · Teratology · 1973 · 55 citations
Recent Advances in Medical Diagnosis and Treatment
A. H. Douthwaite · BMJ · 1938 · 38 citations · Full text